Travere Therapeutics (TVTX) Capital Expenditures Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 16.27% |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 120.83% |
| Jun 30, 2024 | -7.32% |
| Dec 31, 2023 | 26.50% |
| Sep 30, 2023 | -83.93% |
| Jun 30, 2023 | -78.69% |
| Mar 31, 2023 | 44.69% |
| Dec 31, 2022 | 32.57% |
| Sep 30, 2022 | -63.39% |
| Jun 30, 2022 | 104.08% |
| Mar 31, 2022 | 90.33% |
| Dec 31, 2021 | 30.29% |
| Sep 30, 2021 | 40.44% |
| Jun 30, 2021 | -43.20% |
| Mar 31, 2021 | 386.66% |
| Dec 31, 2020 | -23.10% |
| Sep 30, 2020 | 84.89% |
| Jun 30, 2020 | 12.45% |
| Mar 31, 2020 | -37.15% |
| Dec 31, 2019 | -27.37% |
| Sep 30, 2019 | 92.76% |
| Mar 31, 2019 | -7.49% |
| Dec 31, 2018 | -282.41% |
| Sep 30, 2018 | 175.89% |
| Jun 30, 2018 | 419.87% |
| Mar 31, 2018 | 15.98% |
| Dec 31, 2017 | -105.73% |
| Sep 30, 2017 | 34.38% |
| Jun 30, 2017 | -5.44% |
| Mar 31, 2017 | 71.50% |
| Dec 31, 2016 | 143.44% |
| Mar 31, 2016 | 51.94% |